ENDRA Life Sciences Inc. — Balance Sheet Charts
17 snapshots of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Working Capital Components
Total Assets↑+22.1% +$2M
$9M
Current Assets↑+25.6% +$2M
$8M
Cash & Equivalents
—
Receivables↓-100.0% -$7K
$0
Inventory↑+419.8% +$476K
$590K
Net PPE↓-10.2% -$24K
$212K
Total Liabilities↓-33.9% -$820K
$2M
Current Liabilities↓-52.4% -$1M
$987K
Account Payables↓-68.5% -$876K
$403K
Long-Term Debt
—
Short-Term Debt
—
Stockholders Equity↑+50.6% +$2M
$7M
Retained Earnings↓-26.8% -$12M
$-57M
Operating Lease ROU Asset↓-16.3% -$66K
$339K
Operating Lease Liability↓-14.8% -$61K
$348K
Gross PP&E↑+5.8% +$40K
$719K
Accumulated Depreciation↑+20.4% +$99K
$586K
Total Debt Carrying Amount
—
Contract Liability
—